Relevance of temozolomide for elderly patients with MGMT promoter-methylated malignant astrocytomas outside the RTK I methylation group. Relevance of temozolomide for elderly patients with MGMT promoter-methylated malignant astrocytomas outside the RTK I methylation group
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA506921
下载链接
链接失效反馈官方服务：
资源简介：
The data contains Illumina 450k/EPIC array methylation files from 104 patients of the NOA-08 study comparing temozolomide alone vs. radiotherapy in elderly patients with glioblastoma Overall design: Out of the 373 patients included in the NOA-08 study, tissue for biomarker analysis was available in 104 patients. PPFE tissue was used to characterize methylation profiles of these patient tumors with 450k/EPIC arrays
创建时间：
2018-11-26
